Investment Rating - The industry rating is "Recommended" [3] Core Insights - The report highlights the ongoing decline in pork prices, with the average price of live pigs at 12.64 CNY/kg, down 3.05% week-on-week, indicating a supply surplus in the market. However, upcoming festivals are expected to boost consumption and potentially stabilize prices [2][13] - The report emphasizes the importance of improving grain yield through advanced agricultural practices and technology, particularly in the context of food security and the promotion of genetically modified crops [1][12] Summary by Sections Planting Industry Chain - The Ministry of Agriculture and Rural Affairs is focusing on enhancing grain yields through a comprehensive approach tailored to specific crops and regions. This includes promoting high-performance agricultural machinery and addressing storage issues in different regions [1][12] - Companies like Beidahuang and Suqian Agricultural Development are expected to benefit from these initiatives, along with seed companies such as Dabeinong and Longping High-Tech [1][12] Swine Farming - The current average price of live pigs is 12.64 CNY/kg, reflecting a significant decrease due to oversupply. A meeting was held to discuss reducing the breeding sow population by approximately 1 million to stabilize prices [2][13] - The report suggests that the swine industry will focus on quality improvement and efficiency, with a gradual elimination of outdated production capacity. Companies like Muyuan Foods and Wen's Foodstuffs are highlighted as key players to watch [2][5][13] Key Agricultural Product Data Tracking - Corn: The average price is 2360.47 CNY/ton, down 0.10% week-on-week [26] - Wheat: The average price is 2434.39 CNY/ton, up 0.23% week-on-week [29] - Soybeans: The average price is 4050.42 CNY/ton, up 0.17% week-on-week [38] - Cotton: The average price is 15090.00 CNY/ton, down 0.89% week-on-week [46] Feed and Vitamin Prices - The average price of pig feed is 2.68 CNY/kg, with no change week-on-week. Vitamin E prices have decreased by 7.84% to 51.70 CNY/kg [52][63]

Core Viewpoint - The animal health sector experienced a rise of 1.59% on September 26, with Bio-Pharmaceuticals leading the gains, while the overall market indices, Shanghai Composite and Shenzhen Component, saw declines of 0.65% and 1.76% respectively [1] Group 1: Market Performance - The animal health sector's individual stock performance showed significant variations, with Bio-Pharmaceuticals closing at 9.34, up by 7.23%, and a trading volume of 1.0367 million shares, resulting in a turnover of 973 million yuan [1] - Other notable performers included Huisheng Biological at 20.68, up by 1.87%, and Ruipu Biological at 20.93, up by 1.60% [1] Group 2: Capital Flow - The animal health sector saw a net inflow of 86.5157 million yuan from institutional investors, while retail investors experienced a net outflow of 44.7995 million yuan [2] - The capital flow data indicates that major stocks like Bio-Pharmaceuticals had a net inflow of 12.63% from institutional investors, despite a significant outflow from retail and speculative investors [3]

Market Overview - On September 25, the animal health sector declined by 1.62% compared to the previous trading day, with the leading stock, Driveline, experiencing a drop of 4.04% [1] - The Shanghai Composite Index closed at 3853.3, down 0.01%, while the Shenzhen Component Index closed at 13445.9, up 0.67% [1] Stock Performance - The following stocks in the animal health sector showed notable declines: - Driveline (Code: 838275) closed at 9.50, down 4.04% with a trading volume of 19,300 lots [1] - Shunlian Bio (Code: 688098) closed at 10.43, down 3.43% with a trading volume of 76,300 lots [1] - Yongshun Bio (Code: 839729) closed at 9.74, down 2.89% with a trading volume of 20,800 lots [1] - Other notable declines include *ST Green Health (Code: 002868) down 2.39% and Shoufeng Holdings (Code: 002141) down 2.33% [1] Capital Flow - The animal health sector saw a net outflow of 113 million yuan from institutional investors, while retail investors experienced a net inflow of 61.16 million yuan [1] - The following stocks had significant capital flow: - Zhongmu Co. (Code: 600195) had a net inflow of 986,800 yuan from institutional investors [2] - Pulaike (Code: 603566) saw a net inflow of 764,200 yuan from retail investors [2] - *ST Green Health (Code: 002868) experienced a net outflow of 6.71 million yuan from institutional investors [2]

Core Insights - The "pet economy" in China is experiencing rapid growth, with policies and activities being launched to support this sector, leading to increased interest in related stocks [1] - The market size of China's pet industry has grown significantly, from 97.8 billion yuan in 2015 to 592.8 billion yuan in 2023, with a compound annual growth rate (CAGR) of 25.4% [2] - By 2025, the market is expected to reach 811.4 billion yuan, and projections suggest it could reach 1.15 trillion yuan by 2028 [2] Industry Growth Dynamics - The pet market is driven by strong demand, with a variety of companies emerging to focus on pet-related products and services [2] - Key segments such as pet food, healthcare, and cleaning products are currently the largest and fastest-growing areas within the market [3] - There is still significant room for growth in the pet industry, with potential for market size to double in the coming years [3] Policy Support - Local governments are increasingly providing policy support to boost the pet economy, with initiatives aimed at encouraging traditional industries to engage in pet product development [3][4] - Specific regions, such as Wuxi and Anhui, are implementing measures to enhance the pet economy, including promoting technological innovation and e-commerce in the sector [3] Corporate Activities - Several listed companies are actively investing in the pet sector, with notable acquisitions and the establishment of subsidiaries focused on pet food and products [5][6] - Companies like Huang Shang Huang and Three Squirrels are making strategic investments to expand their presence in the pet food market [5] - Jinhe Biological has launched a pet-focused app, indicating a trend towards integrating technology with pet care services [6]

证券日报网讯 9月24日晚间，金河生物发布公告称，公司于2025年8月18日召开第六届董事会第二十九 次会议、第六届监事会第二十四次会议，审议通过《关于注销2024年股票期权激励计划部分股票期权的 议案》。根据相关规定，鉴于《激励计划》授予的激励对象中3名在职激励对象2024年度个人绩效考核 结果为差，前述激励对象已获授但尚未行权的合计17.50万份股票期权由公司予以注销。2025年9月24 日，经中国证券登记结算有限责任公司深圳分公司审核确认，上述17.50万份股票期权的注销事宜已办 理完成。 （编辑 任世碧） ...

金河生物科技股份有限公司 关于部分股票期权注销完成的公告 本公司及董事会全体人员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 金河生物科技股份有限公司（以下简称"公司"）于2025年8月18日召开第 六届董事会第二十九次会议、第六届监事会第二十四次会议，审议通过《关于注 销2024年股票期权激励计划部分股票期权的议案》。根据《上市公司股权激励管 理办法》（以下简称"《管理办法》"）、《金河生物科技股份有限公司2024 年股票期权激励计划》（以下简称"《激励计划》"）等相关规定，鉴于《激励 计划》授予的激励对象中3名在职激励对象2024年度个人绩效考核结果为差，前 述激励对象已获授但尚未行权的合计17.50万份股票期权由公司予以注销。具体 内容详见公司2025年8月20日在《证券时报》《中国证券报》《上海证券报》《证 券日报》和巨潮资讯网（http://www.cninfo.com.cn）披露的《关于注销2024 年股票期权激励计划部分股票期权的公告》。 2025年9月24日，经中国证券登记结算有限责任公司深圳分公司审核确认， 上述17.50万份股票期权的注销事宜已办理 ...

证券代码：002688 证券简称：金河生物 公告编号：2025-090 金河生物科技股份有限公司 第六届董事会第三十一次会议决议公告 本公司及董事会全体人员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 二、备查文件 1、第六届董事会第三十一次会议决议 2、深交所要求的其它文件 特此公告。 金河生物科技股份有限公司 董 事 会 2025 年 9 月 24 日 金河生物科技股份有限公司（以下简称"公司"）第六届董事会第三十一次 会议于 2025 年 9 月 21 日以电子邮件方式发出通知，并于 2025 年 9 月 24 日以通 讯方式召开，会议由董事长王东晓先生主持，应到董事 9 人，实到董事 9 人，本 次董事会出席会议董事人数符合法律法规，会议合法有效。会议召开符合《中华 人民共和国公司法》等法律、法规和《公司章程》的规定。与会董事以通讯表决 的方式审议通过了以下议案： 一、以 9 票同意，0 票反对，0 票弃权审议通过了《关于向银行申请流动资 金贷款授信额度的议案》。 同意公司向鄂尔多斯银行股份有限公司呼和浩特分行申请人民币 3 亿元流 动资金贷款授信额度，期限为 ...

Group 1 - The company has been approved to issue 145,132,743 shares at a price of RMB 5.65 per share, raising a total of approximately RMB 820 million, with a net amount of approximately RMB 802 million after deducting issuance costs [2][3] - The company has established a special account for the raised funds and signed a four-party supervision agreement with its subsidiary, the sponsor, and the bank to ensure proper management and usage of the funds [3][4] - The special account is designated solely for temporary liquidity support and cannot be used for any other purposes, ensuring compliance with regulatory requirements [3][5] Group 2 - The four-party supervision agreement includes provisions for monitoring the use of raised funds, requiring the sponsor to conduct semi-annual inspections and ensuring that any withdrawals exceeding RMB 50 million or 20% of the net raised funds are reported [5][6] - The agreement stipulates strict compliance with anti-corruption laws and regulations, prohibiting any party from soliciting or providing benefits outside the agreement [7][8] - The agreement will remain in effect until all funds are fully utilized and the account is legally closed, with any disputes to be resolved through arbitration in Shanghai [7][8]

Core Points - The animal health sector experienced a decline of 0.36% on September 22, with Jinhe Biology leading the drop [1] - The Shanghai Composite Index closed at 3828.58, up 0.22%, while the Shenzhen Component Index closed at 13157.97, up 0.67% [1] Stock Performance Summary - The following stocks in the animal health sector showed notable performance: - Shoufeng Holdings (002141) closed at 3.94, up 3.14% with a trading volume of 307,400 shares and a turnover of 118 million yuan [1] - ST Lvkang (002868) closed at 28.23, up 2.43% with a trading volume of 24,900 shares and a turnover of 69.04 million yuan [1] - Shengbiotech (600201) closed at 9.11, up 1.22% with a trading volume of 396,800 shares and a turnover of 364 million yuan [1] - Jinhe Biology (002688) closed at 6.74, down 2.18% with a trading volume of 234,800 shares and a turnover of 158 million yuan [2] - Other stocks such as Haili Biology (603718) and Zhongmu Co. (600195) also experienced declines of 1.43% and 1.39% respectively [1][2] Capital Flow Analysis - On that day, the animal health sector saw a net outflow of 53.34 million yuan from institutional investors, while retail investors contributed a net inflow of 67.06 million yuan [2]

证券代码：002688 证券简称：金河生物 公告编号：2025-089 单位：万元 | 开户主体 | 开户行 | 银行账号 | 存放资金金 额（万元） | 募集资金用途 | | --- | --- | --- | --- | --- | | 金河佑本 | 招商银行股份有限公 | 471901636110000 | 0 | 闲置募集资金暂 时补充流动资金 | | | 司呼和浩特分行 | | | 的专项存储和使 | | | | | | 用 | 三、《募集资金四方监管协议》主要内容 金河生物科技股份有限公司 关于开立募集资金暂时补充流动资金专户 并签订募集资金四方监管协议的公告 本公司及董事会全体人员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 一、募集资金基本情况 根据 2020 年 12 月 4 日中国证监会核发的《关于核准金河生物科技股份有限 公司非公开发行股票的批复》（证监许可[2020]3344 号）文核准，金河生物科 技股份有限公司（以下简称"公司"）获准非公开发行 145,132,743 股，每股面 值人民币 1 元，发行价格为每股人民币 5.65 元，实际募 ...